IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000065 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
117,625
Total Value
$971,992.84
P&L
+inf% (+$3,353,922.55)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Finance & CFO | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 28,729 | $0.00 | $0.00 | 139,229 | Direct | โ | View Details | |
EVP, Finance & CFO | Common Stock | โ | Jan 16, 2026 | Sale | 12,922 | $75.22 | $971,992.84 | 126,307 | Direct | โ | View Details | |
EVP, Finance & CFO | Performance Restricted Stock Units | Derivative | Jan 15, 2026 | Grant/Award | 34,360 | $0.00 | $0.00 | 120,995 | Direct | โ | View Details | |
EVP, Finance & CFO | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 28,729 | $0.00 | $0.00 | 55,940 | Direct | โ | View Details | |
EVP, Finance & CFO | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 12,885 | $0.00 | $0.00 | 68,825 | Direct | โ | View Details |